Clinical and Experimental Pediatrics

대한소아청소년과학회 (The Korean Pediatric Society)
권호 표지
DOI QR코드

DOI QR Code

Risk factors of ocular involvement in children with mitochondrial respiratory chain complex defect

  • Chae, Jung-Hyun (Department of Pediatrics, Gangnam Severance Hospital, Severance Children's Hospital, Yonsei University College of Medicine) ;
  • Lee, Jung-Hun (Department of Pediatrics, Gangnam Severance Hospital, Severance Children's Hospital, Yonsei University College of Medicine) ;
  • Kim, Kyo-Ryung (Department of Pediatrics, Gangnam Severance Hospital, Severance Children's Hospital, Yonsei University College of Medicine) ;
  • Byeon, Suk-Ho (The Institute of Vision Research, Department of Ophthalmology, Severance Hospital, Yonsei University College of Medicine) ;
  • Lee, Young-Mock (Department of Pediatrics, Gangnam Severance Hospital, Severance Children's Hospital, Yonsei University College of Medicine) ;
  • Kang, Hoon-Chul (Department of Pediatrics, Gangnam Severance Hospital, Severance Children's Hospital, Yonsei University College of Medicine) ;
  • Lee, Joon-Soo (Department of Pediatrics, Gangnam Severance Hospital, Severance Children's Hospital, Yonsei University College of Medicine) ;
  • Kim, Heung-Dong (Department of Pediatrics, Gangnam Severance Hospital, Severance Children's Hospital, Yonsei University College of Medicine)
  • 투고 : 2010.09.15
  • 심사 : 2010.11.03
  • 발행 : 2010.12.15
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Purpose: Mitochondrial dysfunction can present with various symptoms depending on the organ it has affected. This research tried to analyze the ophthalmologic symptoms and ophthalmologic examination (OE) results in patients with mitochondrial disease (MD). Methods: Seventy-four patients diagnosed with mitochondrial respiratory chain complex defect with biochemical enzyme assay were included in the study. They were divided into 2 groups based on the OE results by funduscopy and were analyzed on the basis of their clinical features, biochemical test results, morphological analysis, and neuroimaging findings. Results: Thirty-seven (50%) of the 74 MD patients developed ophthalmologic symptoms. Abnormal findings were observed in 36 (48.6%) patients during an OE, and 16 (21.6%) of them had no ocular symptoms. Significantly higher rates of prematurity, clinical history of epilepsy or frequent apnea events, abnormal light microscopic findings in muscle pathology, diffuse cerebral atrophy in magnetic resonance imaging, and brainstem hyperintensity and lactate peaks in magnetic resonance spectroscopy were noted in the group with abnormal OE results. Conclusion: Although the ophthalmologic symptoms are not very remarkable in MD patients, an OE is required. When the risk factors mentioned above are observed, a more active approach should be taken in the OE because a higher frequency of ocular involvement can be expected.

키워드

참고문헌

  1. Oldfors A, Tulinius M. Mitochondrial encephalomyopathies. J Neuropathol Exp Neurol 2003;62:217-27. https://doi.org/10.1093/jnen/62.3.217
  2. Schmiedel J, Jackson S, Schafer J, Reichmann H. Mitochondrial cytopathies. J Neurol 2003;250:267-77. https://doi.org/10.1007/s00415-003-0978-3
  3. Lee YM, Kang HC, Lee JS, Kim SH, Kim EY, Lee SK, et al. Mitochondrial respiratory chain defects: underlying etiology in various epileptic conditions. Epilepsia 2008;49:685-90. https://doi.org/10.1111/j.1528-1167.2007.01522.x
  4. Kang HC, Kwon JW, Lee YM, Kim HD, Lee HJ, Hahn SH. Nonspecific mitochondrial disease with epilepsy in children: diagnostic approaches and epileptic phenotypes. Childs Nerv Syst 2007;23:1301-7. https://doi.org/10.1007/s00381-007-0369-7
  5. Fadic R, Johns DR. Clinical spectrum of mitochondrial diseases. Semin Neurol 1996;16:11-20. https://doi.org/10.1055/s-2008-1040954
  6. Debray FG, Lambert M, Chevalier I, Robitaille Y, Decarie JC, Shoubridge EA, et al. Long-term outcome and clinical spectrum of 73 pediatric patients with mitochondrial diseases. Pediatrics 2007;119:722-33. https://doi.org/10.1542/peds.2006-1866
  7. Mullie MA, Harding AE, Petty RK, Ikeda H, Morgan-Hughes JA, Sanders MD. The retinal manifestations of mitochondrial myopathy. A study of 22 cases. Arch Ophthalmol 1985;103:1825-30. https://doi.org/10.1001/archopht.1985.01050120059020
  8. Rose LV, Rose NT, Elder JE, Thorburn DR, Boneh A. Ophthalmologic presentation of oxidative phosphorylation diseases of childhood. Pediatr Neurol 2008;38:395-7. https://doi.org/10.1016/j.pediatrneurol.2008.02.003
  9. Isashiki Y, Nakagawa M, Ohba N, Kamimura A, Sakoda Y, Higuchi I, et al. Retinal manifestations in mitochondrial diseases associated with mitochondrial DNA mutation. Acta Ophthalmol Scand 1998;76:6-13. https://doi.org/10.1034/j.1600-0420.1998.760103.x
  10. Mojon D. Eye disease in mitochondrial encephalomyopathies. Ther Umsch 2001;58:49-55. https://doi.org/10.1024/0040-5930.58.1.49
  11. Michaelides M, Moore AT. The genetics of strabismus. J Med Genet 2004;41:641-6. https://doi.org/10.1136/jmg.2004.021667
  12. Bau V, Zierz S. Update on chronic progressive external ophthalmoplegia. Strabismus 2005;13:133-42. https://doi.org/10.1080/09273970500216432
  13. Schoser BG, Pongratz D. Extraocular mitochondrial myopathies and their differential diagnoses. Strabismus 2006;14:107-13. https://doi.org/10.1080/09273970600701218
  14. Rustin P, Chretien D, Bourgeron T, Gerard B, Rotig A, Saudubray JM, Munnich A. Biochemical and molecular investigations in respiratory chain deficiencies. Clin Chim Acta 1994;228:35-51. https://doi.org/10.1016/0009-8981(94)90055-8
  15. Sperl W. Diagnosis and therapy of mitochondriopathies. Wien Klin Wochenschr 1997;109:93-9.
  16. Gillis L, Kaye E. Diagnosis and management of mitochondrial diseases. Pediatr Clin North Am 2002;49:203-19. https://doi.org/10.1016/S0031-3955(03)00115-9
  17. Finsterer J. Mitochondriopathies. Eur J Neurol 2004;11:163-86. https://doi.org/10.1046/j.1351-5101.2003.00728.x
  18. Jarrett SG, Lin H, Godley BF, Boulton ME. Mitochondrial DNA damage and its potential role in retinal degeneration. Prog Retin Eye Res 2008;27:596-607. https://doi.org/10.1016/j.preteyeres.2008.09.001
  19. Ballinger SW, Van Houten B, Jin GF, Conklin CA, Godley BF. Hydrogen peroxide causes significant mitochondrial DNA damage in human RPE cells. Exp Eye Res 1999;68:765-72. https://doi.org/10.1006/exer.1998.0661
  20. Jarrett SG, Boulton ME. Poly(ADP-ribose) polymerase offers protection against oxidative and alkylation damage to the nuclear and mitochondrial genomes of the retinal pigment epithelium. Ophthalmic Res 2007;39:213-23. https://doi.org/10.1159/000104683
  21. Abu-Shaweesh JM, Martin RJ. Neonatal apnea: what's new? Pediatr Pulmonol 2008;43:937-44. https://doi.org/10.1002/ppul.20832
  22. Kirby DM, Crawford M, Cleary MA, Dahl HH, Dennett X, Thorburn DR. Respiratory chain complex I deficiency: an underdiagnosed energy generation disorder. Neurology 1999;52:1255-64. https://doi.org/10.1212/WNL.52.6.1255
  23. Wray SH, Provenzale JM, Johns DR, Thulborn KR. MR of the brain in mitochondrial myopathy. Am J Neuroradiol 1995;16:1167-73.
  24. Valanne L, Ketonen L, Majander A, Suomalainen A, Pihko H. Neuroradiologic findings in children with mitochondrial disorders. Am J Neuroradiol 1998;19:369-77.
  25. Kim J, Lee SK, Kim EY, Kim DI, Lee YM, Lee JS, et al. Neuroradiologic findings in children with mitochondrial disorder: correlation with mitochondrial respiratory chain defects. Eur Radiol 2008;18:1741-8. https://doi.org/10.1007/s00330-008-0921-1